|
US6440421B1
(en)
|
1996-04-18 |
2002-08-27 |
Auchkland Uniservices Limited |
Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
|
|
US5888963A
(en)
*
|
1996-04-18 |
1999-03-30 |
Auckland Uniservices Limited |
Treatment of bone disorders with adrenomedullin
|
|
AU9369098A
(en)
|
1997-09-26 |
1999-04-23 |
Auckland Uniservices Limited |
Therapeutic method
|
|
EP1214600B1
(en)
|
1999-09-10 |
2005-12-21 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Determination of adrenomedullin-binding proteins
|
|
WO2002040571A1
(en)
*
|
2000-11-17 |
2002-05-23 |
Lee Jin Kyu |
Poly (methylsilsesquioxane) copolymers and preparation method thereof
|
|
FR2821080B1
(fr)
*
|
2001-02-20 |
2003-12-19 |
Sanofi Synthelabo |
Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques
|
|
US20110087312A1
(en)
*
|
2001-03-02 |
2011-04-14 |
Erchonia Corporatin |
Method for Treatment of Diabetes and Prediabetes with Low-Level Laser Therapy
|
|
CA2441228A1
(en)
|
2001-03-23 |
2002-10-03 |
Aphton Corporation |
Combination treatment of pancreatic cancer
|
|
US20090191232A1
(en)
|
2001-05-04 |
2009-07-30 |
Gevas Philip C |
Combination therapy for the treatment of tumors
|
|
AU2003221096A1
(en)
*
|
2002-03-19 |
2003-09-29 |
Oncorex, Inc. |
Peptides, medicinal compositions containing the peptide and medicinal compositions for treating cancer
|
|
US20040127445A1
(en)
*
|
2002-08-28 |
2004-07-01 |
Chondrogene Limited |
Beta-2 microglobulin (B2M) and B2M related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
|
|
US20040121375A1
(en)
*
|
2002-09-30 |
2004-06-24 |
Bayer Pharmaceuticals Corporation |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
|
AU2003249012A1
(en)
*
|
2002-09-30 |
2004-04-23 |
Japan As Represented By The President Of The University Of Tokyo |
Genes and polypeptides relating to human myeloid leukemia
|
|
US7364719B2
(en)
|
2002-10-04 |
2008-04-29 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vasoregulating compounds and methods of their use
|
|
AU2003295422B2
(en)
|
2002-11-07 |
2009-01-29 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
A new target for angiogenesis and anti-angiogenesis therapy
|
|
US7235376B2
(en)
|
2003-03-28 |
2007-06-26 |
Receptor Biologix, Inc. |
Gastrin hormone immunoassays
|
|
US7228658B2
(en)
|
2003-08-27 |
2007-06-12 |
Weyerhaeuser Company |
Method of attaching an end seal to manufactured seeds
|
|
AU2004273057C1
(en)
*
|
2003-09-08 |
2011-06-30 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide
|
|
US8691575B2
(en)
*
|
2003-09-30 |
2014-04-08 |
Weyerhaeuser Nr Company |
General method of classifying plant embryos using a generalized Lorenz-Bayes classifier
|
|
US20050108935A1
(en)
*
|
2003-11-25 |
2005-05-26 |
Edwin Hirahara |
Method and system of manufacturing artificial seed coats
|
|
CA2484533C
(en)
*
|
2003-11-25 |
2008-12-02 |
Weyerhaeuser Company |
Systems and method of embryo delivery for manufactured seeds
|
|
CA2486289C
(en)
*
|
2003-11-25 |
2008-01-08 |
Weyerhaeuser Company |
Combination end seal and restraint
|
|
US20050108929A1
(en)
*
|
2003-11-25 |
2005-05-26 |
Edwin Hirahara |
Method and system for creating manufactured seeds
|
|
US7555865B2
(en)
*
|
2003-11-25 |
2009-07-07 |
Weyerhaeuser Nr Company |
Method and system of manufacturing artificial seed coats
|
|
US7356965B2
(en)
*
|
2003-12-11 |
2008-04-15 |
Weyerhaeuser Co. |
Multi-embryo manufactured seed
|
|
US7591287B2
(en)
*
|
2003-12-18 |
2009-09-22 |
Weyerhaeuser Nr Company |
System and method for filling a seedcoat with a liquid to a selected level
|
|
US7568309B2
(en)
*
|
2004-06-30 |
2009-08-04 |
Weyerhaeuser Nr Company |
Method and system for producing manufactured seeds
|
|
EP2567974A3
(en)
|
2004-09-22 |
2013-05-22 |
Cancer Advances, Inc., |
Monoclonal antibodies to progastrin
|
|
US20060070145A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Carlson William C |
Manufactured seed having a live end seal
|
|
CA2518279A1
(en)
*
|
2004-09-27 |
2006-03-27 |
Weyerhaeuser Company |
Manufactured seed having a live end seal coating
|
|
US7547488B2
(en)
*
|
2004-12-15 |
2009-06-16 |
Weyerhaeuser Nr Company |
Oriented strand board panel having improved strand alignment and a method for making the same
|
|
US7654037B2
(en)
*
|
2005-06-30 |
2010-02-02 |
Weyerhaeuser Nr Company |
Method to improve plant somatic embryo germination from manufactured seed
|
|
US8168592B2
(en)
|
2005-10-21 |
2012-05-01 |
Amgen Inc. |
CGRP peptide antagonists and conjugates
|
|
US8906857B2
(en)
*
|
2005-12-01 |
2014-12-09 |
B.R.A.H.M.S. Gmbh |
Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
|
|
JP4976412B2
(ja)
*
|
2005-12-01 |
2012-07-18 |
ベー・エル・アー・ハー・エム・エス・ゲーエムベーハー |
エンドセリン、エンドセリンアゴニスト及びアドレノメジュリンアンタゴニストによる危篤患者の診断及び治療のための方法
|
|
DE102006052916A1
(de)
*
|
2006-11-08 |
2008-05-15 |
Brahms Aktiengesellschaft |
Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM
|
|
AU2008303893A1
(en)
*
|
2007-09-11 |
2009-04-02 |
Mondobiotech Laboratories Ag |
Use of adrenomedullin as a therapeutic agent for the treatment of excessive angiogenesis
|
|
FR2934597B1
(fr)
*
|
2008-07-31 |
2013-04-19 |
Univ Aix Marseille Ii |
Anticorps se liant aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament.
|
|
CN102203607A
(zh)
*
|
2008-10-31 |
2011-09-28 |
B.R.A.H.M.S有限公司 |
根据对心血管系统的影响将食物和/或饮料和/或饮食和/或营养疗法和/或药物进行分类的方法和测定方法
|
|
DK3178835T3
(da)
|
2009-02-03 |
2019-06-24 |
Amunix Pharmaceuticals Inc |
Forlængede rekombinante polypeptider og sammensætninger omfattende samme
|
|
EP2389799A1
(en)
*
|
2010-05-25 |
2011-11-30 |
BioMass Booster, S.L. |
Method for increasing plant biomass
|
|
US20130177901A1
(en)
*
|
2010-06-18 |
2013-07-11 |
Cezanne S.A.S. |
Markers for the prognosis and risk assessment of pregnancy-induced hypertension and preeclampsia
|
|
FR2964103B1
(fr)
*
|
2010-08-30 |
2018-11-23 |
Universite D'aix-Marseille |
Anticorps se liant a l'adrenomedulline et aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament
|
|
JP5932279B2
(ja)
*
|
2011-10-07 |
2016-06-08 |
ポーラ化成工業株式会社 |
スクリーニング方法
|
|
US8776012B2
(en)
*
|
2011-10-25 |
2014-07-08 |
International Business Machines Corporation |
Automatic scheduling of review meetings
|
|
PL3553084T3
(pl)
|
2011-11-16 |
2023-04-17 |
Adrenomed Ag |
Przeciwciało przeciwko adrenomedulinie (adm) lub fragment przeciwciała przeciwko adm lub szkielet przeciwko adm inny niż ig do profilaktyki lub zmniejszania zaburzenia czynności narządu lub niewydolności narządu u pacjenta cierpiącego na przewlekłą lub ostrą chorobę lub ostry stan
|
|
HRP20191771T1
(hr)
|
2011-11-16 |
2019-12-27 |
Adrenomed Ag |
Anti-adrenomedulin (adm) antitijelo ili fragment anti-adm antitijela ili anti-adm non-ig skela za uporabu u terapiji akutne bolesti ili akutnog stanja pacijenta za stabiliziranje cirkulacije
|
|
HRP20190122T1
(hr)
|
2011-11-16 |
2019-03-08 |
Adrenomed Ag |
Protutijelo protiv adrenomedulina (adm) ili fragment protutijela protiv adm ili okosnica ne-ig protiv adm, namijenjeni reguliranju ravnoteže tekućina kod pacijenta s kroničnom ili akutnom bolešću
|
|
US9140696B2
(en)
*
|
2011-11-16 |
2015-09-22 |
Adrenomed Ag |
Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-IG scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
|
|
JP5953108B2
(ja)
*
|
2012-05-14 |
2016-07-20 |
ポーラ化成工業株式会社 |
スクリーニング方法
|
|
WO2014054798A1
(ja)
*
|
2012-10-04 |
2014-04-10 |
独立行政法人国立循環器病研究センター |
悪性腫瘍転移抑制用医薬
|
|
US10793626B2
(en)
*
|
2013-12-20 |
2020-10-06 |
Angiobiomed Gmbh |
Adrenomedullin binder for use in therapy of cancer
|
|
EP3067093B1
(en)
*
|
2015-03-12 |
2019-08-07 |
Fundacion Rioja Salud |
Use of an inhibitor of adrenomedullin for the manufacture of a drug useful in the prevention and treatment of diseases that reduce bone density
|
|
CA3064962A1
(en)
|
2017-05-26 |
2018-11-29 |
National Research Council Of Canada |
Self-assembling peptide for activating human mast cells
|
|
IL271427B2
(en)
|
2017-06-15 |
2025-08-01 |
Cancer Advances Inc |
Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
|
|
US12150978B2
(en)
|
2017-06-15 |
2024-11-26 |
Cancer Advances Inc. |
Compositions and methods for preventing tumors and cancer
|
|
EP3438668A1
(en)
*
|
2017-08-04 |
2019-02-06 |
B.R.A.H.M.S GmbH |
Diagnosis and risk stratification of fungal infections
|
|
JP7366007B2
(ja)
|
2017-09-13 |
2023-10-20 |
ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング |
プロアドレノメジュリンに基づく輸液療法のガイダンスのための方法
|
|
EP3682247B1
(en)
|
2017-09-13 |
2022-02-09 |
B.R.A.H.M.S GmbH |
Proadrenomedullin as a marker for abnormal platelet levels
|
|
EP3502706A1
(en)
|
2017-12-20 |
2019-06-26 |
B.R.A.H.M.S GmbH |
Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
|
|
EP3578989A1
(en)
|
2018-06-06 |
2019-12-11 |
B.R.A.H.M.S GmbH |
Pro-adm for prognosis of trauma-related complications in polytrauma patients
|
|
EP4058466A1
(en)
|
2019-11-13 |
2022-09-21 |
Amunix Pharmaceuticals, Inc. |
Barcoded xten polypeptides and compositions thereof, and methods for making and using the same
|